Exactech, Inc. (NASDAQ:EXAC) was upgraded by stock analysts at BidaskClub from a “sell” rating to a “hold” rating in a note issued to investors on Friday.

Other equities analysts have also recently issued reports about the company. Gabelli restated a “buy” rating on shares of Exactech in a report on Monday, July 31st. TheStreet upgraded Exactech from a “c+” rating to a “b” rating in a report on Tuesday, April 25th. Finally, Zacks Investment Research upgraded Exactech from a “sell” rating to a “hold” rating in a report on Tuesday, April 25th.

Shares of Exactech (NASDAQ:EXAC) traded up 1.53% during mid-day trading on Friday, hitting $29.95. 30,587 shares of the company were exchanged. The company has a market capitalization of $429.72 million, a price-to-earnings ratio of 575.96 and a beta of 1.02. The firm has a 50 day moving average of $29.41 and a 200 day moving average of $28.11. Exactech has a 12-month low of $22.20 and a 12-month high of $31.90.

Exactech (NASDAQ:EXAC) last posted its quarterly earnings results on Thursday, July 27th. The medical equipment provider reported $0.33 earnings per share (EPS) for the quarter, hitting analysts’ consensus estimates of $0.33. The firm had revenue of $67.30 million for the quarter, compared to analysts’ expectations of $67.75 million. Exactech had a return on equity of 7.39% and a net margin of 0.30%. The company’s revenue for the quarter was up 1.8% compared to the same quarter last year. During the same period in the prior year, the business earned $0.31 EPS. Equities research analysts forecast that Exactech will post $1.29 earnings per share for the current year.

WARNING: This piece of content was reported by American Banking News and is the property of of American Banking News. If you are reading this piece of content on another domain, it was copied illegally and republished in violation of international trademark & copyright laws. The correct version of this piece of content can be accessed at https://www.americanbankingnews.com/2017/08/19/exactech-inc-exac-upgraded-to-hold-by-bidaskclub.html.

In other Exactech news, Director William B. Locander sold 988 shares of the stock in a transaction that occurred on Wednesday, May 31st. The stock was sold at an average price of $30.34, for a total transaction of $29,975.92. Following the transaction, the director now directly owns 8,555 shares in the company, valued at approximately $259,558.70. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, Director Fern Watts sold 1,013 shares of the stock in a transaction that occurred on Tuesday, August 8th. The stock was sold at an average price of $29.04, for a total value of $29,417.52. Following the transaction, the director now owns 4,727 shares in the company, valued at $137,272.08. The disclosure for this sale can be found here. Insiders have sold a total of 10,358 shares of company stock worth $314,311 over the last 90 days. Company insiders own 28.30% of the company’s stock.

Several institutional investors have recently bought and sold shares of the company. Kirr Marbach & Co. LLC IN boosted its position in Exactech by 1.2% in the first quarter. Kirr Marbach & Co. LLC IN now owns 10,760 shares of the medical equipment provider’s stock worth $271,000 after buying an additional 125 shares during the last quarter. The Manufacturers Life Insurance Company boosted its position in Exactech by 3.2% in the second quarter. The Manufacturers Life Insurance Company now owns 9,323 shares of the medical equipment provider’s stock worth $278,000 after buying an additional 289 shares during the last quarter. American International Group Inc. boosted its position in Exactech by 7.1% in the first quarter. American International Group Inc. now owns 6,423 shares of the medical equipment provider’s stock worth $162,000 after buying an additional 424 shares during the last quarter. ClariVest Asset Management LLC boosted its position in Exactech by 5.4% in the first quarter. ClariVest Asset Management LLC now owns 10,908 shares of the medical equipment provider’s stock worth $275,000 after buying an additional 554 shares during the last quarter. Finally, Teachers Advisors LLC boosted its position in Exactech by 2.7% in the second quarter. Teachers Advisors LLC now owns 21,549 shares of the medical equipment provider’s stock worth $642,000 after buying an additional 568 shares during the last quarter. Hedge funds and other institutional investors own 64.05% of the company’s stock.

Exactech Company Profile

Exactech, Inc develops, manufactures, markets, distributes and sells orthopedic implant devices, related surgical instrumentation and biologic services to hospitals and physicians. The Company’s segments include knee, hip, biologics and spine, extremity and other products. Its other products segment includes miscellaneous sales categories, such as bone cement, instrument rental fees, shipping charges and other product lines.

Receive News & Ratings for Exactech Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Exactech Inc. and related companies with MarketBeat.com's FREE daily email newsletter.